Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Five Prime Therapeutics Inc (FPRX)’

Medical treatments, advanced medical equipment, medical devices

Cabiralizumab From Five Prime Therapeutics Inc (FPRX) Obtains Orphan Designation

The European Commission has certified orphan designation for cabiralizumab. The investigational antibody from Five Prime Therapeutics Inc (NASDAQ:FPRX......(read more)
Healthcare Careers That Require a Master’s Degree

Bristol-Myers Squibb Co (BMY) Agrees To Extend Research With Five Prime Therapeutics Inc (FPRX)

Bristol-Myers Squibb Co (NYSE:BMY) has opted to extend the research term of its discovery collaboration agreement with Five Prime Therapeutics Inc (NASDAQ......(read more)

Why Do Hedge Funds Like Five Prime Therapeutics?

Five Prime Therapeutics Inc (NASDAQ:FPRX) is a $1.25 billion biotech company that focuses on the discovery and development of protein therapeutics that......(read more)
Insider Trading

Battered Performance Sports Group Ltd (PSG) and Two Strong-Performing Companies Witness Insider Buying

According to fresh data from CNBC, the dollar value of all insider purchases in April has been the lowest in the past 11 months or so. Meanwhile, the......(read more)

Why Are These Stocks Surging Today?

It’s Thursday and shareholders of BofI Holding, Inc. (NASDAQ:BOFI), and Five Prime Therapeutics Inc (NASDAQ:FPRX) are certainly happy as the value......(read more)

Has Five Prime Therapeutics Inc. (FPRX) Turned The Corner? Adage Capital Thinks So

Adage Capital Management, founded by Phill Gross and Robert Atchinson, recently disclosed an ownership stake of 2.66 million shares in Five Prime Therapeutics......(read more)
SAC CAPITAL ADVISORS

Healthways, Inc. (HWAY): Point72 Discloses New 6.5% Position as Company Considers Strategic Options

Steve Cohen’s Point72 Asset Management disclosed a new position in Healthways, Inc. (NASDAQ:HWAY) in a filing with the SEC on Wednesday. The filing......(read more)

Zeltiq Aesthetics Inc (ZLTQ), Five Prime Therapeutics Inc (FPRX): Point72’s Latest Bullish Moves

Steve Cohen’s Point72 Asset Management has made bullish moves into a pair of medical technology stocks. According to separate filings with the SEC,......(read more)

Adage Capital Management Ups Stake in Five Prime Therapeutics Inc (FPRX)

In a new filing with the U.S. Securities and Exchange Commission, Adage Capital Management, managed by Phill Gross and Robert Atchinson, has disclosed......(read more)

Healthcor Management Increases Holding in CareView Communications Inc (CRVW)

Arthur Cohen and Joseph Healey‘s Healthcor Management has upped its exposure to CareView Communications Inc (OTCBB:CRVW). Healthcor currently......(read more)

Healthcor Management Reduces Position in Allscripts Healthcare Solutions Inc (MDRX)

Arthur Cohen and Joseph Healey‘s Healthcor Management, revealed, in a newly amended filing with the SEC, decreasing its holding in Allscripts Healthcare......(read more)

Healthcor Management Reveals New Passive Stake in Five Prime Therapeutics

Arthur Cohen and Joseph Healey‘s Healthcor Management has added Five Prime Therapeutics Inc (NASDAQ:FPRX) to its equity portfolio, a new filing......(read more)